On October 6, 2026, Sanara MedTech Inc. sold all assets of its wholly owned subsidiary, Tissue Health Plus LLC, including business software products and related intellectual property, to an unrelated third party for approximately $2,000,000 and received certain earnout rights. The company operates in the medical technology sector.
